Plasminogen activator inhibitor-1 4G/5G polymorphism and retinopathy risk in type 2 diabetes: a meta-analysis

BACKGROUND: Mounting evidence has suggested that plasminogen activator inhibitor-1 (PAI-1) is a candidate for increased risk of diabetic retinopathy. Studies have reported that insertion/deletion polymorphism in the PAI-1 gene may influence the risk of this disease. To comprehensively address this i...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Tengyue, Pang, Chong, Li, Ningdong, Zhou, Elaine, Zhao, Kanxing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3565939/
https://www.ncbi.nlm.nih.gov/pubmed/23281898
http://dx.doi.org/10.1186/1741-7015-11-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3565939/
https://www.ncbi.nlm.nih.gov/pubmed/23281898
http://dx.doi.org/10.1186/1741-7015-11-1

Ejemplares similares